299 related articles for article (PubMed ID: 15203373)
21. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
23. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
24. [Epidemiological analysis of the etiological relationship between primary hepatocarcinoma and hepatitis B virus].
Ding ZR
Zhonghua Liu Xing Bing Xue Za Zhi; 1984 Jun; 5(3):146-9. PubMed ID: 6097361
[No Abstract] [Full Text] [Related]
25. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
[TBL] [Abstract][Full Text] [Related]
26. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
27. SEN virus infection and the risk of hepatocellular carcinoma: a case-control study.
Tangkijvanich P; Theamboonlers A; Sriponthong M; Kullavanijaya P; Poovorawan Y
Am J Gastroenterol; 2003 Nov; 98(11):2500-4. PubMed ID: 14638355
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
Omata M; Ashcavai M; Liew CT; Peters RL
Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
Ka MM; Ndiaye MF; Herve P; Legueno B; Diop BM; Dangou JM; Niang A; Woto-Gaye G; Mendes V; Diop TM; Ndiaye PD; Bao O
Dakar Med; 1996; Spec No():59-62. PubMed ID: 14520992
[No Abstract] [Full Text] [Related]
30. The epidemiology of hepatocellular carcinoma.
Johnson PJ
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study.
Ohishi W; Fujiwara S; Cologne JB; Suzuki G; Akahoshi M; Nishi N; Takahashi I; Chayama K
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):846-54. PubMed ID: 18398026
[TBL] [Abstract][Full Text] [Related]
34. Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study.
Giannini EG; Savarino V; Risso D; Di Nolfo MA; Del Poggio P; Benvegnù L; Farinati F; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Liver Int; 2011 Feb; 31(2):192-6. PubMed ID: 21143580
[TBL] [Abstract][Full Text] [Related]
35. Diet and hepatocellular carcinoma: a case-control study in Greece.
Kuper H; Tzonou A; Lagiou P; Mucci LA; Trichopoulos D; Stuver SO; Trichopoulou A
Nutr Cancer; 2000; 38(1):6-12. PubMed ID: 11341045
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of malignant liver tumors].
Rodella S; Picoco C
Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
[TBL] [Abstract][Full Text] [Related]
37. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
Jee SH; Ohrr H; Sull JW; Samet JM
J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis.
Badawi AF; Michael MS
Anticancer Res; 1999; 19(5C):4565-9. PubMed ID: 10650811
[TBL] [Abstract][Full Text] [Related]
39. [Modelling the general relative risk models in case-control studies of primary hepatocellular carcinoma].
Zhao N; Yu SZ; Sun WM
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):331-6. PubMed ID: 7895581
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China.
Yeh FS; Mo CC; Yen RC
Natl Cancer Inst Monogr; 1985 Dec; 69():47-8. PubMed ID: 3010122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
